SCHEMBL31000937

CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O

nearest known ligand 0.63

Predicted protein targets (top 11)

	gene	UniProt	supporting neighbours	confidence
▸	F2	P00734	4/20	0.63

▸	CALCR	P30988	4/20	0.63

▸	NPY2R	P49146	7/20	0.60

▸	NPY4R	P50391	7/20	0.60

▸	NPY5R	Q15761	7/20	0.60

▸	NPY1R	P25929	5/20	0.60

▸	CRHR1	P34998	1/20	0.60

▸	CRHR2	Q13324	1/20	0.60

▸	HCRTR1	O43613	1/20	0.60

▸	HCRTR2	O43614	1/20	0.60

▸	MC4R	P32245	1/20	0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30726629	0.98	F2 (0.63)	F2CALCRNPY2RNPY4RNPY5R
SCHEMBL29742947	0.97	F2 (0.62)	F2CALCRNPY2RNPY4RNPY5R
SCHEMBL30607303	0.90	CALCR (0.69)	F2CALCRNPY2RNPY4RNPY5R
SCHEMBL29884239	0.89	CALCR (0.69)	F2CALCRNPY2RNPY4RNPY5R
SCHEMBL31745572	0.88	CALCR (0.63)	F2CALCRNPY2RNPY4RNPY5R
SCHEMBL31014074	0.88	CALCR (0.75)	F2CALCRNPY2RNPY4RNPY5R
SCHEMBL30844080	0.88	CALCR (0.67)	F2CALCRCRHR1CRHR2HCRTR1
SCHEMBL30495631	0.88	F2 (0.66)	F2CALCRNPY2RNPY4RNPY5R
SCHEMBL29679847	0.88	F2 (0.63)	F2CALCRNPY2RNPY4RNPY5R
SCHEMBL30973953	0.87	C5AR1 (0.63)	CALCRNPY2RNPY4RNPY5RNPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4630447-A2	ANTIBODIES OR FRAGMENTS THEREOF FOR SARS-COV-2 AND VARIANTS THEREOF	Abwiz Bio, Inc. (US)	2025-10-15	—	—	EP	disclosed
WO-2024124241-A2	ANTIBODIES OR FRAGMENTS THEREOF FOR SARS-COV-2 AND VARIANTS THEREOF	ABWIZ BIO, INC. (US)	2024-06-13	—	—	WO	disclosed